You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 166 No. 20, November 13, 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Colon Cancer
 •Surgery
 •Surgical Interventions
 •Colorectal Surgery
 •Diagnosis
 •Screening
 •Gastroenterology
 •Gastrointestinal Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Colon Cancer Screening

The Good, the Bad, and the Ugly

Arch Intern Med. 2006;166:2177-2179.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

This year, it is estimated that there will be 55 170 colorectal cancer (CRC)–related deaths, making it the second leading cause of cancer-related deaths among Americans.1 If detected early, CRC is eminently curable; however, given the insidious nature of CRC, only about one third of patients are diagnosed as having the cancer at the localized stage.1 This underscores the need for effective screening of the population at risk, primarily those older than 50 years. There are several recommended CRC screening tests, including fecal occult blood tests (FOBTs), flexible sigmoidoscopy, and air-contrast barium enema, spanning a range of cost, invasiveness, discomfort, and accuracy.2 Fecal occult blood testing is the least expensive intrusive test, whereas colonoscopy is the most accurate but also the most invasive test. Fecal occult blood testing and colonoscopy have been proved to not only decrease mortality but also prevent CRC occurrence (by 20% and 65%-90%, respectively) through identification and . . . [Full Text of this Article]


AUTHOR INFORMATION
Hemant K. Roy, MD; Vadim Backman, PhD; Michael J. Goldberg, MD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

The Use of Screening Colonoscopy for Patients Cared for by the Department of Veterans Affairs
Hashem B. El-Serag, Laura Petersen, Howard Hampel, Peter Richardson, and Gregory Cooper
Arch Intern Med. 2006;166(20):2202-2208.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Association between Rectal Optical Signatures and Colonic Neoplasia: Potential Applications for Screening
Roy et al.
Cancer Res. 2009;69:4476-4483.
ABSTRACT | FULL TEXT  

Rectal Mucosal Microvascular Blood Supply Increase Is Associated with Colonic Neoplasia
Gomes et al.
Clin. Cancer Res. 2009;15:3110-3117.
ABSTRACT | FULL TEXT  

Colorectal Cancer Risk: Black, White, or Shades of Gray?
Roy and Bianchi
JAMA 2008;300:1459-1461.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.